5X23
Crystal structure of CYP2C9 genetic variant A477T (*30) in complex with multiple losartan molecules
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-17A |
Synchrotron site | Photon Factory |
Beamline | BL-17A |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-06-13 |
Detector | ADSC QUANTUM 270 |
Wavelength(s) | 0.98 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 74.952, 142.273, 161.831 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.510 - 2.000 |
R-factor | 0.21923 |
Rwork | 0.217 |
R-free | 0.25308 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1r9o |
RMSD bond length | 0.025 |
RMSD bond angle | 2.501 |
Data reduction software | HKL-2000 |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0072) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 45.510 | 2.070 |
High resolution limit [Å] | 2.000 | 2.000 |
Rmerge | 0.070 | 0.590 |
Number of reflections | 58476 | 5733 |
<I/σ(I)> | 32.2 | 2.4 |
Completeness [%] | 99.1 | 98.6 |
Redundancy | 6.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 291 | 1.5 M ammonium sulfate, 0.1 M Tris pH8.5, 12% glycerol |